Do no harm: Surgeons should be leaders in opioid stewardship Authors: Amy N Antonsen, Sam M Wiseman Published: 2026 ABSTRACT SummaryDrug overdose has killed tens of thousands of people in Canada. Surgery and postoperative opioid prescriptions introduce narcotics to opioid-naive patients, with risk as high as 13% for prolonged opioid use long after surgical recovery. Surgeons in North America prescribe opioids to more patients, and in much higher doses, to manage postoperative pain than surgeons in other countries for similar procedures. Yet, most postoperatively prescribed opioids often go unused by patients in North America. With 90% of opioids not taken as prescribed, this excess supply stocks the community for nonmedical opioid use. With opioid overdoses posing a public health crisis, we call on surgeons to be leaders in responsible opioid prescribing to reduce adverse effects of opioid use while maintaining adequate postoperative pain control. Tens of thousands of people in Canada have died from drug overdose in recent years. Ample evidence has identified surgery and postoperative opioid prescriptions as triggering events introducing opioidnaive patients to narcotics, with risk as high as 13% for prolonged opioid use among surgical patients long after the expected resolution of surgical pain.1–3 A public health emergency was declared in the United States in 2017 because of the opioid crisis, and discourse urging surgeons to improve opioid stewardship is not new. Yet, 9 years later, enormous variation and substantial excess remain in postoperative opioid prescribing, which may be exacerbated by an absence of unified education and guidelines related to opioid stewardship. As the prescribers of many patients’ first opioids, surgeons should be leaders in reducing avoidable opioid prescriptions, which could help to limit the ongoing public health crisis. Western countries, including Canada and the US, prescribe far more opioids for postoperative pain management than other countries. Although this began with efforts in the 1990s to improve postoperative pain control and to address sociodemographic biases in the provision of analgesia, it was fueled by false claims that opioids were not addictive, leading to a massive increase in opioid prescribing and culminating in the opioid epidemic. 1,4 In 2020, 91% of patients in the US undergoing appendectomy, cholecystectomy, or inguinal hernia repair were prescribed opioids, compared with only 5% of patients who underwent these procedures outside the US.4 Patients in the US were prescribed higher doses, with a median of 150 (range 0 to 1680) mg oral morphine equivalents (OME) for Americans compared with a median of 0 (range 0 to 600) mg OME for patients outside the US, and they were also more likely to receive refills.4 Although this difference could reflect cultural nuance in pain experience, prescribed opioids in the US go mostly unused, suggesting that many are not needed for adequate pain control. A systematic review and meta-analysis of 810 patients in the US receiving an opioid prescription after surgery (including inpatient and outpatient obstetrical, thoracic, orthopedic, and urologic surgery) found that 67% to 92% of patients did not use all their prescribed medications, with as many as 21% using none of their prescribed narcotics.2 Overall, among 6 included studies, 42% to 71% of prescribed analgesics were not taken. The most common reason patients reported for not taking them was adequate control of pain, confirming that the opioid prescription was in excess of what was required for that purpose.2 Furthermore, only 4% to 9% of patients disposed of their excess analgesics in a manner suggested by the US Food and Drug Administration, and 73% to 77% of patients stored their excess analgesics in an unlocked location where they would be accessible for misuse.2 With 90% of opioids not taken as prescribed, this excess supply of prescribed analgesics is helping to stock the community for nonmedical opioid use. New persistent opioid use, defined as postoperative opioid use after surgical pain that would be expected to resolve, is an important postoperative complication with considerable associated risk. In a large cohort of patients, 5.9% of those undergoing minor surgery (e.g., laparoscopic cholecystectomy, varicose vein removal) and 6.5% of those undergoing major surgery (e.g., colectomy, hysterectomy) filled an opioid prescription between 90 and 180 days after their operation compared with 0.4% of controls, suggesting an increased risk.3 There was no difference between patients undergoing major versus minor surgery, but preoperative tobacco use, alcohol and substance use disorders, mood disorders, and anxiety and pain disorders were risk factors for new persistent opioid use. This suggests that analgesic requirements, patients’ experience of pain, and risks associated with opioid prescription do not depend on the extent of the surgical procedure; rather, it is multifactorial and intersectional with patients’ experiences and comorbidities. Addiction, new prolonged opioid use, and substance use disorders following first opioid exposure after surgery can happen to anyone, but marginalized groups are disproportionately affected.1 Stacking layers of social disadvantage can lead to poverty, homelessness, and further marginalization. Harm reduction interventions have emerged to reduce mortality from opioid use disorder and opioid overdose, but large-scale public efforts to improve safety and provide public support to community groups have remained inconsistent. With most evidence tracking prolonged opioid use following surgery capturing only prescriptions filled, the true effect of postoperative opioid prescriptions leading to nonprescription drug use and of reliance on an unpredictable nonmedical supply are not well described in the literature but ultimately contribute to lives lost. With known risk of addiction and diversion, how can surgeons provide adequate analgesia for postoperative pain while mitigating risks? Many jurisdictions have implemented guidelines around opioid prescribing for postoperative pain. For example, in 2017 the state of Michigan disseminated the Opioid Prescribing Engagement Network (OPEN) guideline, which recommends maximum amounts of prescribed opioids following common procedures; the average quantity of opioids prescribed postoperatively subsequently decreased from 200 mg to 89 mg OME.5 New persistent postoperative opioid use also fell from 3.29% to 2.51%.5 Similar findings were observed with quality initiatives in Ontario to reduce opioid prescribing after breast surgery and other common general surgery procedures.6,7 For example, a community teaching hospital in Ontario implemented a guideline for postoperative opioid prescribing after laparoscopic cholecystectomy and appendectomy that resulted in a decrease in the median number of opioid pills prescribed by 50% and a decrease in the median number of opioid pills consumed to 0, without a change in patients’ pain satisfaction scores.6 With many comparable programs showing promising results, these observations suggest that reducing opioid prescriptions may contribute to a decrease in new persistent opioid use. As they are responsible for many patients’ initial exposure to opioids, surgeons have an obligation to practise opioid stewardship and to educate patients, learners, and colleagues on the risks and consequences of excessive opioid prescribing. Evidence-based guidelines currently exist (Box 1), but buy-in from surgeons is essential to ensure best postoperative opioid prescribing practices, help mitigate the propagation of the opioid crisis, and improve patient safety.1 Highlights from the CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022), pertaining to postoperative opioid prescribing1 Findings Opioids have similar or less effectiveness for pain and function than nonsteroidal anti-inflammatory drugs and acetaminophen for many conditions. Opioids have similar or less effectiveness for pain and function than nonsteroidal anti-inflammatory drugs and acetaminophen for many conditions. Opioids are associated with small improvements in short-term pain and function compared with placebo, but also have more associated short-term harms. Opioids are associated with small improvements in short-term pain and function compared with placebo, but also have more associated short-term harms. There is no reliable way to predict which patients will experience significant harm from opioids or which patients will benefit most. There is no reliable way to predict which patients will experience significant harm from opioids or which patients will benefit most. The dosage of postoperative opioids administered in hospital before discharge can help predict opioid requirements for pain management after discharge. The dosage of postoperative opioids administered in hospital before discharge can help predict opioid requirements for pain management after discharge. Recommendations When prescribing opioids, clinicians should prescribe immediate-release opioids at the lowest effective dose, for no longer than the expected duration of pain severe enough to require opioids. When prescribing opioids, clinicians should prescribe immediate-release opioids at the lowest effective dose, for no longer than the expected duration of pain severe enough to require opioids. Clinicians should discuss expected benefits, risks, and alternatives to opioids and involve patients meaningfully in the decision to prescribe opioids or not. Clinicians should counsel patients on the risks of over-dose, withdrawal, and serious opioid use disorder as well as expected effects, including constipation, nausea, and drowsiness. Clinicians should advise patients that the goal of therapy is to reduce pain to a manageable level, not to eliminate it entirely. Clinicians should discuss expected benefits, risks, and alternatives to opioids and involve patients meaningfully in the decision to prescribe opioids or not. Clinicians should counsel patients on the risks of over-dose, withdrawal, and serious opioid use disorder as well as expected effects, including constipation, nausea, and drowsiness. Clinicians should advise patients that the goal of therapy is to reduce pain to a manageable level, not to eliminate it entirely. Clinicians should avoid prescribing additional opioids in case pain lasts longer than expected. Clinicians, practices, and health systems should have mechanisms in place to support patients whose severe acute pain lasts longer than expected. Clinicians should avoid prescribing additional opioids in case pain lasts longer than expected. Clinicians, practices, and health systems should have mechanisms in place to support patients whose severe acute pain lasts longer than expected. CDC = US Centers for Disease Control and Prevention. Footnotes Competing interests: None declared. Contributors: Sam Wiseman conceived of this work. Amy Antonsen acquired the data and wrote the article. Both authors revised it critically for important intellectual content, gave final approval of the version to be published, and agreed to be accountable for all aspects of the work. References